Cargando…
Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
OBJECTIVES: Studies of the use of IV N-acetylcysteine in the management of non-acetaminophen-induced acute liver failure have evaluated various dosing regimens. The only randomized trial studying this application described a 72-hour regimen. However, observational studies have reported extended dura...
Autores principales: | Bass, Stephanie N., Lumpkin, Mollie, Mireles-Cabodevila, Eduardo, Lindenmeyer, Christina C., Dolan, Bridget, Pickett, Caleigh, Kapoor, Aanchal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133178/ https://www.ncbi.nlm.nih.gov/pubmed/34036270 http://dx.doi.org/10.1097/CCE.0000000000000411 |
Ejemplares similares
-
Therapeutic plasma exchange in liver failure
por: Chris-Olaiya, Abimbola, et al.
Publicado: (2021) -
The role of N-acetylcysteine in the treatment of non-acetaminophen acute liver failure
por: Teriaky, Anouar
Publicado: (2017) -
N-acetylcysteine for non-acetaminophen induced acute liver failure: A review
por: Jiang, Shirley Xue, et al.
Publicado: (2022) -
LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics
por: Lindenmeyer, Christina C, et al.
Publicado: (2020) -
N-acetylcysteine overdose after acetaminophen poisoning
por: Mahmoudi, Ghafar Ali, et al.
Publicado: (2015)